0000856984 false 0000856984 2023-10-05 2023-10-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (date of earliest event reported): October 5, 2023

 

QHSLab, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

0-19041

(Commission File No.)

 

Nevada   30-1104301

(State

of Incorporation)

 

(I.R.S. Employer

Identification No.)

     

901 Northpoint Parkway Suite 302 West Palm Beach

FL 33407

  33407
(Address of Principal Executive Offices)   (ZIP Code)

 

Registrant’s telephone number, including area code: (929) 379-6503

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   USAQ   N/A

 

 

 

 
 

 

Item 1.01 Entry into Material Definitive Agreement

 

On August 10, 2021, QHSLab, Inc. (the ‘Company”) entered into a Securities Purchase Agreement with Mercer Street Global Opportunity Fund (“Buyer”), pursuant to which it issued to Buyer the Company’s Original Issue Discount Secured Convertible Promissory Note in the principal amount of $806,000 (the “Note”). The principal amount of the Note, together with all interest accrued thereon was initially convertible into shares of common stock of the Company at a conversion price of $0.65 per share. In July 2022, the Company and the Buyer entered into a Securities Purchase Agreement pursuant to which the Company issued to Buyer the Company’s Original Issue Discount Secured Convertible Promissory Note in the principal amount of $440,000 (the “Second Note,” collectively with the Note, the “Notes”). The principal amount of the Second Note, together with all interest accrued thereon is convertible into shares of common stock of the Company at a conversion price of $0.20 per share. Pursuant to the anti-dilution provisions of the Note, the price at which the principal amount and interest accrued on the Note can be converted into shares of common stock of the Company was automatically reduced to $0.20 per share.

 

On October 5, 2023, at the request of the Holder, the Company agreed to reduce the conversion price with respect to $10,500 of the amounts payable pursuant to the Note to two and one-half ($0.025) cents per share. The balance of the amounts payable pursuant to the Note and the Second Note remain convertible into shares of common stock of the Company at a price of twenty ($0.20) cents per share. The Company is currently in default of its obligations under the Note and the Second Note and there can be no assurance as to whether the Holder may seek to exercise its rights under the Notes or seek further concessions from the Company, including a reduction in the conversion price of additional amounts due under the Notes.

 

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits.

 

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

 

Exhibit

No.

  Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: October 6, 2023  
     
QHSLab, Inc.  
     
  /s/ Troy Grogan  
Name:  Troy Grogan  
Title: CEO and Chairman  

 

 

v3.23.3
Cover
Oct. 05, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 05, 2023
Entity File Number 0-19041
Entity Registrant Name QHSLab, Inc.
Entity Central Index Key 0000856984
Entity Tax Identification Number 30-1104301
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 901 Northpoint Parkway
Entity Address, Address Line Two Suite 302
Entity Address, City or Town West Palm Beach
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33407
City Area Code (929)
Local Phone Number 379-6503
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol USAQ

QHSLab (QB) (USOTC:USAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more QHSLab (QB) Charts.
QHSLab (QB) (USOTC:USAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more QHSLab (QB) Charts.